Josh Downing - Cell Therapies

About
Explore Cell Therapies

About Cell Therapies

Our Facility

View our Services

Partnerships and Collaborations

Careers at Cell Therapies

Contact us

Since 2003, Cell Therapies has manufactured cell therapies, ex vivo gene therapies, and regenerative medicine products under GMP standards to meet global regulatory requirements.

Learn about Cell Therapies
Services
Explore Services

Contract Manufacturing

Technology Transfer

Process Development

Analytical Testing and Development

Quality as a Service

Consulting and Advisory

Clinical Trial Support

Cryopreservation & Logistics

Digitalisation & Automation

With over two decades of experience in GMP manufacturing of cell-based products, Cell Therapies is a trusted partner in transforming promising research into scalable, compliant, and commercially viable therapies.

Learn about Our Services
Facility
Careers
Explore Careers

Careers at Cell Therapies

View Current Opportunities

Upload your Resume

We are always on the lookout for curious minds, problem-solvers, and biotech enthusiasts to join our team. If you have a background in GMP manufacturing, QC, QA, engineering, or cell and gene therapy development, we would love to hear from you.

Find out about a career at Cell Therapies
News and Resources
Explore News and Resources

All News and Resources

News

Resources

Filter
All News
Resources

S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility
S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility
Read More

Cell Therapies Joins the ACGMP Alliance
Cell Therapies Joins the ACGMP Alliance
Read More

First Patient Dosed in KOALA CAR-T Trial for Multiple Myeloma
First Patient Dosed in KOALA CAR-T Trial for Multiple Myeloma
Read More

Read the latest from Cell Therapies
Contact

News

S2N.Bio commences technology transfer of Alzheimer’s cell therapy to Cell Therapies’ Melbourne GMP facility

MELBOURNE, Australia — 15th October 2026 — Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced…

Josh DowningOctober 15, 2026

News

Cell Therapies Joins the ACGMP Alliance

IMMEDIATE RELEASE Independent CGT Manufacturers Join Forces to Give Developers one Front Door to Global…

Josh DowningOctober 6, 2026

News

A-SEEDS and Cell Therapies Announce Manufacturing Partnership to Advance Clinical Trials of Novel CAR-T Cell Therapy

Nagano, Japan / Melbourne, Australia– November 19, 2025 A-SEEDS Co., Ltd., a clinical-stage biotechnology company…

Josh DowningNovember 19, 2025

News

Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region

October 1, 2025 — Cell Therapies Pty Ltd. (“Cell Therapies”) and Teijin Limited announced today…

Josh DowningSeptember 30, 2025

News

CTPL sign MoU with Xellera to Fast-Track CGT Access across APAC

Cell Therapies and Xellera Therapeutics Enter into a Strategic Partnership to Fast-Track Access to Cell…

Josh DowningApril 1, 2025

News

Cell Therapies to partner with Chimeric Therapeutics Ltd

Cell Therapies are pleased to announce that they are partnering with Chimeric Therapeutics to…

Josh DowningAugust 9, 2024